PEMETREXED (PEMETREXED DISODIUM) — FDA Approval NDA215179 (SHILPA)
PEMETREXED (PEMETREXED DISODIUM) — FDA Approval NDA215179 (SHILPA) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: PEMETREXED; Active ingredients: PEMETREXED DISODIUM; Application number: NDA215179.
| Brand name | PEMETREXED |
|---|---|
| Active ingredients | PEMETREXED DISODIUM |
| Application number | NDA215179 |
| Sponsor | SHILPA |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Marketing status | Prescription |
| Products in application | 3 |
| First approval date | 20230522 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →